Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritis

Cytokine

Volumn 61, Issue 3, 2013, Pages 759-765

  Llamas Covarrubias, M A ^a   Valle, Y ^a   Bucala, R ^b   Navarro Hernandez R E ^a   Palafox Sanchez C A ^a   Padilla Gutierrez J R ^a   Parra Rojas, I ^c   Bernard Medina, A G ^d   Reyes Castillo, Z ^a   Munoz Valle J F ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^d HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

Author keywords

Disease activity; Early onset; Macrophage migration inhibitory factor; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

BIOLOGICAL PRODUCT; C REACTIVE PROTEIN; CHLOROQUINE; CYTOSINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GUANOSINE; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; ETHNIC GROUP; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84875373810     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.12.032     Document Type: Article

References (54)

1. MacGregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., Aho K., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000, 43:30-37.
2. Mikulowska A., Metz C.N., Bucala R., Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997, 158:5514-5517.
3. Leech M., Metz C., Hall P., Hutchinson P., Gianis K., Smith M., et al. Macrophage migration inhibitory factor: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999, 42:1601-1608.
4. George M., Vaughan J.H. In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med 1962, 111:514-521.
5. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993, 365:756-759.
6. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003, 3:791-800.
7. Calandra T., Bernhagen J., Mitchell R.A., Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994, 179:1895-1902.
8. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., Donnelly T., et al. MIF as a glucocorticoid induced modulator of cytokine production. Nature 1995, 377:68-71.
9. Bacher M., Metz C.N., Calandra T., Mayer K., Chesney J., Lohoff M., et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996, 93:7849-7854.
10. Gregory J.L., Morand E.F., McKeown S.J., Ralph J.A., Hall P., Yang Y.H., et al. Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 2006, 177:8072-8079.
11. Denkinger C.M., Denkinger M., Kort J.J., Metz C., Forsthuber T.G. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol 2003, 170:1274-1282.
12. Pakozdi A., Amin M.A., Haas C.S., Martínez R.J., Haines G.K., Santos L.L., et al. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther 2006, 8:R132.
13. Onodera S., Nishihira J., Iwabuchi K., Koyama Y., Yoshida K., Tanaka S., et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 2002, 277:7865-7874.
14. Mitchell R.A., Liao H., Chesney J., Fingerle-Rowson G., Baugh J., David J., et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002, 99:345-350.
15. Flaster H., Bernhagen J., Calandra T., Bucala R. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol Endocrinol 2007, 21:1267-1280.
16. Onodera S., Tanji H., Suzuki K., Kaneda K., Mizue Y., Sagawa A. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999, 11:163-167.
17. Llamas-Covarrubias M.A., Valle Y., Navarro-Hernández R.E., Guzmán-Guzmán I.P., Ramírez-Dueñas M.G., Rangel-Villalobos H., et al. Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course. Rheumatol Int 2012, 32:2307-2311.
18. Leech M., Metz C., Santos L., Peng T., Holdsworth S.R., Bucala R., et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998, 41:910-917.
19. Santos L., Hall P., Metz C., Bucala R., Morand E.F. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001, 123:309-314.
20. Onodera S., Ohshima S., Tohyama H., Yasuda K., Nishihira J., Iwakura Y., et al. A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum 2007, 56:521-530.
21. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M., et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:2402-2409.
22. Radstake T.R., Sweep F.C., Welsing P., Franke B., Vermeulen S.H., Geurts-Moespot, et al. Correlation of rheumatoid arthritis severity with the genetic functional polymorphisms and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005, 52:3020-3029.
23. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002, 3:170-176.
24. Sreih A.G., Ezzeddine R., Leng L., LaChance A., Yu G., Mizue Y., et al. Dual effect of macrophage migration inhibitory factor gene on the development and the severity of human systemic lupus erythematosus. Arthritis Rheum 2011, 63:3942-3951.
25. Renner P., Roger T., Bochud P.Y., Sprong T., Sweep F.C.G.J., Bochud M., et al. A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease. FASEB J 2011, 26:1-10.
26. Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington J., et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 2003, 4:487-491.
27. Martinez A., Orozco G., Varadé J., Sánchez López M., Pascual D., Balsa A., et al. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immunol 2007, 68:744-747.
28. Rubi-Castellanos R., Martínez-Cortés G., Muñoz-Valle J.F., González-Martín A., Cerda-Flores R.M., Anaya-Palafox M., et al. Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico. Am J Phys Anthropol 2009, 139:284-294.
29. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
30. Prevoo M.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
31. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988, 16:1215.
32. Makhija R., Kingsnorth A., Demaine A. Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis. JOP 2007, 8:289-295.
33. Excoffier L., Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995, 12:921-927.
34. Wright S. The interpretation of population structure by F-statistics with special regard to systems of mating. Evolution 1965, 19:395-420.
35. Hartl, Daniel L. A primer of population genetics 2000, Sinauer. 3rd ed.
36. Lewis PO, Zaykin D. Genetic data analysis: computer program for the analysis of allelic data, 2002.
37. Roff D.A., Bentzen P. The statistical analysis of mitochondrial DNA polymorphisms: chi 2 and the problem of small samples. Mol Biol Evol 1989, 6:539-545.
38. Cardiel M.H., Abello-Banfi M., Ruiz-Mercado R., Alarcon-Segovia D. How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the health assessment questionnaire disability index (Spanish HAQ-DI). Clin Exp Rheumatol 1993, 11:117-121.
39. Miterski B., Drynda S., Böschow G., Klein W., Oppermann J., Kekow J., et al. Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Genet 2004, 5:2.
40. Donn R., Alourfi Z., Zeggini E., Lamb R., Jury F., Lunt M., et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004, 50:1604-1610.
41. Pratt A.G., Isaacs J.D., Mattey D.L. Current concepts in the pathogenesis of early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009, 23:37-48.
42. Totaro M.C., Tolusso B., Napolioni V., Faustini F., Canestri S., et al. PTPN22 1858C>T polymorphism distribution in Europe and Association with rheumatoid arthritis: case-control study and meta-analysis. PLoS ONE 2011, 6:e24292. 10.1371/journal.pone.0024292.
43. Burr M.L., Naseem H., Hinks A., Eyre S., Gibbons L.J., Bowes J., et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis 2010, 69:666-670.
44. Han S., Li Y., Mao Y., Xie Y. Meta-analysis of the association of the CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis. Hum Genet 2005, 118:123-132.
45. Morin P.A., Martien K.K., Taylor B.L. Assessing statistical power of SNPs for population structure and conservation studies. Mol Ecol Resources 2009, 9:66-73. 10.1111/j.1755 0998.2008.02392.x. Epub 2008 Oct 21.
46. Chuang C.C., Chuang Y.C., Chang W.T., Chen C.C., Hor L.I., Huang A.M., et al. Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection. BMC Immunol 2010, 11:50.
47. Chen Y.C., Zhang X.W., Niu X.H., Xin D.Q., Zhao W.P., Na Y.Q., et al. Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer. Oncogene 2010, 29:3067-3078.
48. Beaulieu E., Green L., Elsby L., Alourfi Z., Morand E.F., Ray D.W., et al. Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin. Clin Exp Immunol 2011, 163:178-188.
49. Toh M.L., Aeberli D., Lacey D., Yang Y., Santos L.L., Clarkson M., et al. Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 2006, 177:4818-4825.
50. Sampey A.V., Hall P.H., Mitchell R.A., Metz C.N., Morand E.F. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001, 44:1273-1280.
51. Lacey D., Sampey A., Mitchell R., Bucala R., Santos L., Leech M., et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 2003, 48:103-109.
52. Morand E.F., Leech M., Weedon H., Metz C., Bucala R., Smith D. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology 2002, 41:558-562.
53. Gore Y., Starlets D., Maharshak N., Becker-Herman S., Kaneyuki U., Leng L., et al. Macrophage migration inhibitory factor (MIF) induces B cell survival by activation of a CD74/CD44 receptor complex. J Biol Chem 2008, 283:2784-2792.
54. Bozza M., Satoskar A.R., Lin G., Lu B., Humbless A.A., Gerard C., et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999, 189:341-346.